Daiqing Liao
University of Florida
H-index: 29
North America-United States
Top articles of Daiqing Liao
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Regulation of lipid metabolism and ferroptosis by DAXX | Cancer Research | Wenlin Yang Nikee Awasthee Qi Chen Seth Hale Daiqing Liao | 2024/3/22 |
Discovery of hydrazide-based HDAC8 selective PROTACs | Cancer Research | Yufeng Xiao Yi Liu Nikee Awasthee Chengcheng Meng Michael He | 2024/3/22 |
Polypeptide inhibitor of de novo lipogenesis in cancer cells | 2021/4/22 | ||
Benzoylhydrazide-derived hdac degraders as therapeutics for treating cancer and other human diseases | 2023/6/15 | ||
Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy | Madison E Carelock Rohan P Master Myung-Chul Kim Zeng Jin Lei Wang | 2023/6/1 | |
Abstract LB002: Extracellular vesicle loading of proteolysis targeting chimeras for targeted therapeutic delivery | Cancer Research | Nina Erwin Xiaoshu Pan Nikee Awasthee Yufeng Xiao Guangrong Zheng | 2023/4/14 |
DAXX drives de novo lipogenesis and contributes to tumorigenesis | Nature communications | Iqbal Mahmud Guimei Tian Jia Wang Tarun E Hutchinson Brandon J Kim | 2023/4/12 |
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation | Cell chemical biology | Yufeng Xiao Seth Hale Nikee Awasthee Chengcheng Meng Xuan Zhang | 2023/11/16 |
Selective targeting deacetylase 3 (HDAC3) and HDAC8 by PROTACs | Cancer Research | Yufeng Xiao Seth Hale Nikee Awasthee Xuan Zhang Yi Liu | 2023/4/4 |
HDAC inhibitor compounds and methods of treatment | 2023/8/22 | ||
Abstract LB138: DAXX interacts with sterol regulatory element-binding proteins (SREBPs) to promote oncogenic lipogenesis and tumorigenesis in triple-negative breast cancer | Cancer Research | Iqbal Mahmud Guimei Tian Tarun Hutchison Brandon Kim Daiqing Liao | 2022/6/15 |
Apoptosis, necroptosis, and pyroptosis in health and disease: an overview of molecular mechanisms, targets for therapeutic development, and known small molecule and biologic … | Daiqing Liao | 2022/1/1 | |
Protein phase separation in cell death and survival | Michael C Chung Daiqing Liao Juan Guan | 2022/1/1 | |
Ferroptosis: lipids, iron, cellular defense mechanisms and opportunities for drug development | Daiqing Liao | 2022/1/1 | |
Pharmacological inhibition of CBP/p300 blocks estrogen receptor alpha (ERα) function through suppressing enhancer H3K27 acetylation in luminal breast cancer | Cancers | Aaron Waddell Iqbal Mahmud Haocheng Ding Zhiguang Huo Daiqing Liao | 2021/6/4 |
The DAXX-SREBP axis promotes oncogenic lipogenesis and tumorigenesis | bioRxiv | Iqbal Mahmud Guimei Tian Jia Wang Jessica Lewis Aaron Waddell | 2021/1/3 |
CBP/p300: critical co-activators for nuclear steroid hormone receptors and emerging therapeutic targets in prostate and breast cancers | Aaron R Waddell Haojie Huang Daiqing Liao | 2021/6/8 | |
Two-way horizontal and vertical omics integration for disease subtype discovery | Statistics in Biosciences | Zhiguang Huo Li Zhu Tianzhou Ma Hongcheng Liu Song Han | 2020/4 |
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs | Chemical Communications | Yufeng Xiao Jia Wang Lisa Y Zhao Xinyi Chen Guangrong Zheng | 2020/8/25 |
Pharmacologic inhibition of CBP/p300 suppresses estrogen-induced gene expression and proliferation in ER+ luminal breast cancer cells | Cancer Research | Aaron Richard Waddell Iqbal Mahmud Zhiguang Huo Daiqing Liao | 2020/8/15 |
